Content uploaded by Krzysztof Narkiewicz
Author content
All content in this area was uploaded by Krzysztof Narkiewicz
Content may be subject to copyright.
EDITORIAL
High mortality explained by mildly elevated blood pressure in
Scandinavian adolescent conscripts – A plea for early drug treatment?
SVERRE E. KJELDSEN
1 , SUZANNE OPARIL
2 , KRZYSZTOF NARKIEWICZ
3
& THOMAS HEDNER
4
1 Department of Cardiology, Oslo University Hospital, Ullevaal, Oslo Norway,
2 Vascular Biology and Hypertension
Program, University of Alabama, Birmingham, Alabama, USA,
3 Department of Hypertension and Diabetology,
Medical University of Gdansk, Poland and
4 Department of Medicine, University of Göteborg, Sahlgrenska Academy,
Göteborg, Sweden
The Scandinavian countries have for many years
practiced compulsory military service; in this context
all 18-year-old men are subject to an extensive med-
ical examination prior to enlistment. High blood
pressure detected under such conditions is highly
reproducible (1), and markers of stress such as ele-
vated blood pressure, heart rate and plasma cate-
cholamines during mental stress testing are
reproducible many years later in the same population
(2). Such stress markers predict the development of
hypertension (3), weight gain (4) and insulin resis-
tance (5) in middle age, suggesting that these
pathophysiological mechanisms detected in early
adulthood may underlie the development of cardio-
vascular disease later in life.
A large national study of total mortality, cardio-
vascular mortality and non-cardiovascular mortality
in 1.2 million men in Sweden who underwent mili-
tary conscription examinations between 1969 and
1995 at a mean age of 18.4 years and were followed
for a median of 24 (range 0 – 37) years has recently
been reported (6). During follow-up, 28 934 (2.4%)
men died. The relation of systolic blood pressure to
total mortality was U-shaped, with the lowest risk at
a systolic blood pressure of about 130 mmHg. This
pattern was driven by the relation to non-cardiovas-
cular mortality, whereas the relation to cardiovascu-
lar mortality increased monotonically (higher risk
with higher blood pressure). There was also a relation
between diastolic blood pressure and mortality risk,
which in fact was stronger than that of systolic blood
pressure, in terms of both relative risk and popula-
tion attributable fraction (deaths that could be avoided
if blood pressure was in the optimal range). Relations
to cardiovascular and non-cardiovascular mortality
were similar, with an apparent risk threshold at a
diastolic blood pressure of about 90 mmHg. Below
this threshold level, diastolic blood pressure and
mortality were unrelated, and above this level, risk
increased steeply with higher diastolic blood pres-
sures. Approximately 20% of total mortality in these
young men could be explained by their diastolic
blood pressure.
Though limited to men, mostly of Caucasian
origin, these data (6) strongly enforce the idea that
prevention of cardiovascular disease should start in
early adulthood. We have repeatedly called for pro-
spective data from intervention trials carried out in
people with mild hypertension or even high normal
blood pressure, particularly in the young (7,8).
Based on observational data, we recommend that
adolescents should exercise, maintain ideal body
weight, avoid smoking and generally adhere to a
healthy lifestyle. The Swedish conscript data dem-
onstrated that diastolic blood pressure above 90
mmHg in young men is highly predictive of cardio-
vascular and total mortality. Such fi ndings could be
important to support the concept that pharmaco-
logical treatment of blood pressure should be admin-
istered to at risk persons in this younger age group,
even in the absence of data from randomized con-
trolled trials with hard clinical outcomes. This is
particularly important because it is unlikely that ran-
domized outcome data on late adolescents and
young adults will be performed in the near future or
even ever be collected.
In light of exceptionally well tolerated antihyper-
tensive drugs on the market (9), and their generic
low prices and thus cost effectiveness, we may be
moving towards the point that we extrapolate the
positive outcome data from antihypertensive drug
intervention in the middle-aged and elderly to the
Blood Pressure, 2011; 20: 188–189
ISSN 0 803-7051 pri nt/ ISSN 1651-1999 onlin e © 2011 Scandin avia n Foundat ion for Cardiovasc ular R esear ch
DOI : 10. 3109 /0 8037 051.2 011.595 962
Blood Press Downloaded from informahealthcare.com by Norwegian Knowledge Cntr Health Svcs on 09/27/11
For personal use only.
Editorial 189
young people and support active drug treatment once
blood pressure above certain limits is detected (10,11).
Alternatively or concomitantly, in the world of evi-
denced-based medicine and ethical problems with
extrapolating from the middle-aged and elderly to the
young, we need to investigate the benefi t of drug
treatment of hypertension in the young people by
doing studies with intermediate endpoints, e.g. left
ventricular hypertrophy, vascular remodeling or vas-
cular stiffness, to establish proof of principle that nor-
malization may lead to less cardiovascular endpoints
and reduced blood pressure-related mortality.
References
Rostrup M, Westheim A, Kjeldsen SE, Eide I. Cardiovascular 1.
reactivity, coronary risk factors and sympathetic activity in
young men. Hypertension. 1993;22:891 – 899.
Hassellund S, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M. 2.
Long-term stability of cardiovascular and catecholamine
responses to stress tests: an 18-year follow-up study. Hyper-
tension. 2010;55:131 – 136.
Flaa A, Eide I, Kjeldsen SE, Rostrup M. Sympathoadrenal 3.
reactivity is a predictor of future blood pressure. An 18-year
follow-up study. Hypertension. 2008;52:336 – 341.
Flaa A, Sandvik L, Kjeldsen SE, Eide I, Rostrup M. Does sym-4.
pathoadrenal activity predict changes in body fat? An 18-year
follow-up study. Am J Clin Nutr. 2008;87:1596 – 1601.
Flaa A, Kjeldsen SE, Eide I, Rostrup M. Increased sympa-5.
thetic activity may predict insulin resistance. An 18-year fol-
low-up study. Metabolism. 2008;57:1422 – 1427.
Sundstr ö m J, Neovius M, Tynelius P, Rasmussen F. Associa-6.
tion of blood pressure in late adolescence with subsequent
mortality: Cohort study of Swedish male conscripts. BMJ.
2011;342:d643 doi:10.1136/bmj.d643.
Kjeldsen SE, Hedner T, Himmelmann A. Prevention of car-7.
diovascular disease in uncomplicated, mild hypertension –
Need for prospective data from intervention trials. Blood
Press. 2004;12:5 – 6.
Kjeldsen SE, Oparil S, Narkiewicz K, Hedner T. Should we 8.
treat pre-hypertension? Blood Press. 2009;18:298 – 299.
Kjeldsen SE, Hedner T, Narkiewicz K. Angiotensin receptor 9.
blockers and endpoint protection. Blood Press. 2005;14:
195.
National High Blood Pressure Education Program Working 10.
Group on High Blood Pressure in Children and Adolescents.
The fourth report on the diagnosis, evaluation, and treatment
of high blood pressure in children and adolescents. Pediatrics.
2004;114:555 – 576.
Lurbe E, Cifkova R, Kennedy Cruickshank J, et al. Manage-11.
ment of high blood pressure in children and adolescents:
Recommendations of the European Society of Hypertension.
J Hypertens. 2009;27:1719 – 1742.
Blood Press Downloaded from informahealthcare.com by Norwegian Knowledge Cntr Health Svcs on 09/27/11
For personal use only.